Celularity Inc Quarterly Nonoperating Income (Expense) in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Celularity Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2019 to Q3 2024.
  • Celularity Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$4.57M, a 185% decline year-over-year.
  • Celularity Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$19.3M, a 387% decline year-over-year.
  • Celularity Inc annual Nonoperating Income (Expense) for 2023 was -$4M, a 110% decline from 2022.
  • Celularity Inc annual Nonoperating Income (Expense) for 2022 was $39.8M, a 344% increase from 2021.
  • Celularity Inc annual Nonoperating Income (Expense) for 2021 was $8.96M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$19.3M -$4.57M -$9.95M -185% Jul 1, 2024 Sep 30, 2024 10-Q 2024-12-06
Q2 2024 -$9.33M $3.69M +$9.16M Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$18.5M -$14.6M -$14.5M -9857% Jan 1, 2024 Mar 31, 2024 10-Q 2024-10-16
Q4 2023 -$4M -$3.76M -$10.7M -154% Oct 1, 2023 Dec 31, 2023 10-K 2024-07-30
Q3 2023 $6.72M $5.38M -$5.05M -48.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-12-06
Q2 2023 $11.8M -$5.47M -$49.1M -113% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 $60.9M -$147K +$21.1M +99.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-10-16
Q4 2022 $39.8M $6.96M -$3.97M -36.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-07-30
Q3 2022 $43.8M $10.4M -$28.6M -73.3% Jul 1, 2022 Sep 30, 2022 10-Q 2024-01-03
Q2 2022 $72.4M $43.7M +$47.5M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $24.9M -$21.3M +$15.9M +42.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $8.96M $10.9M +$37.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$28.4M $39M +$80.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$109M -$3.87M -$3.89M -14702% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$105M -$37.1M -$44M -640% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$61M -$26.4M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$41.5M -$43.1M -2660% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $26.5K -$892K -97.1% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $6.88M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q3 2019 $1.62M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $919K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.